Letter

Data on effect of HRT on breast cancer conflict with other data

BMJ 2000; 321 doi: 10.1136/bmj.321.7254.179 (Published 15 July 2000)
Cite this as: BMJ 2000;321:179.1

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. R Vidya, research fellow,
  2. J M Dixon, consultant surgeon (jmd@wght.demon.co.uk)
  1. Edinburgh Breast Unit, Western General Hospital, Edinburgh EH4 2XU

    EDITOR—Stallard et al suggest that breast tumours that develop in users of hormone replacement therapy have no favourable prognostic features.1 Their data conflict with those reported by other groups 2 3 and with data from our unit.

    View this table:
    • In this window
    • In a new window

    Comparison of tumour characteristics in users and non-users of hormone replacement therapy. Values are …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    Read related article

    See previous polls

    BMJ most popular